Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia

Rehab Nabil Shamma, Mona Hassan AburahmaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptAbstract: Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of hypertension and various edematous condition...

Full description

Bibliographic Details
Main Authors: Shamma RN, Aburahma MH
Format: Article
Language:English
Published: Dove Medical Press 2014-11-01
Series:International Journal of Nanomedicine
Online Access:http://www.dovepress.com/follicular-delivery-of-spironolactone-via-nanostructured-lipid-carrier-peer-reviewed-article-IJN
id doaj-7c655fd69f81415da22950fdaacee805
record_format Article
spelling doaj-7c655fd69f81415da22950fdaacee8052020-11-24T22:04:19ZengDove Medical PressInternational Journal of Nanomedicine1178-20132014-11-012014Issue 15449546019303Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopeciaShamma RNAburahma MH Rehab Nabil Shamma, Mona Hassan AburahmaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptAbstract: Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of hypertension and various edematous conditions. SL has gained a lot of attention for treating androgenic alopecia due to its potent antiandrogenic properties. Recently, there has been growing interest for follicular targeting of drug molecules for treatment of hair and scalp disorders using nanocolloidal lipid-based delivery systems to minimize unnecessary systemic side effects associated with oral drug administration. Accordingly, the objective of this study is to improve SL efficiency and safety in treating alopecia through the preparation of colloidal nanostructured lipid carriers (NLCs) for follicular drug delivery. SL-loaded NLCs were prepared by an emulsion solvent diffusion and evaporation method using 23 full factorial design. All of the prepared formulations were spherical in shape with nanometric size range (215.6–834.3 nm) and entrapment efficiency >74%. Differential scanning calorimetry thermograms and X-ray diffractograms revealed that SL exists in amorphous form within the NLC matrices. The drug release behavior from the NLCs displayed an initial burst release phase followed by sustained release of SL. Confocal laser scanning microscopy confirmed the potential of delivering the fluorolabeled NLCs within the follicles, suggesting the possibility of using SL-loaded NLCs for localized delivery of SL into the scalp hair follicles.Keywords: spironolactone, androgenic alopecia, nanostructured lipid carriers, follicular targeting, confocal laser scanning microscopyhttp://www.dovepress.com/follicular-delivery-of-spironolactone-via-nanostructured-lipid-carrier-peer-reviewed-article-IJN
collection DOAJ
language English
format Article
sources DOAJ
author Shamma RN
Aburahma MH
spellingShingle Shamma RN
Aburahma MH
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
International Journal of Nanomedicine
author_facet Shamma RN
Aburahma MH
author_sort Shamma RN
title Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
title_short Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
title_full Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
title_fullStr Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
title_full_unstemmed Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
title_sort follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia
publisher Dove Medical Press
series International Journal of Nanomedicine
issn 1178-2013
publishDate 2014-11-01
description Rehab Nabil Shamma, Mona Hassan AburahmaDepartment of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, EgyptAbstract: Spironolactone (SL) is a US Food and Drug Administration-approved drug for the treatment of hypertension and various edematous conditions. SL has gained a lot of attention for treating androgenic alopecia due to its potent antiandrogenic properties. Recently, there has been growing interest for follicular targeting of drug molecules for treatment of hair and scalp disorders using nanocolloidal lipid-based delivery systems to minimize unnecessary systemic side effects associated with oral drug administration. Accordingly, the objective of this study is to improve SL efficiency and safety in treating alopecia through the preparation of colloidal nanostructured lipid carriers (NLCs) for follicular drug delivery. SL-loaded NLCs were prepared by an emulsion solvent diffusion and evaporation method using 23 full factorial design. All of the prepared formulations were spherical in shape with nanometric size range (215.6–834.3 nm) and entrapment efficiency >74%. Differential scanning calorimetry thermograms and X-ray diffractograms revealed that SL exists in amorphous form within the NLC matrices. The drug release behavior from the NLCs displayed an initial burst release phase followed by sustained release of SL. Confocal laser scanning microscopy confirmed the potential of delivering the fluorolabeled NLCs within the follicles, suggesting the possibility of using SL-loaded NLCs for localized delivery of SL into the scalp hair follicles.Keywords: spironolactone, androgenic alopecia, nanostructured lipid carriers, follicular targeting, confocal laser scanning microscopy
url http://www.dovepress.com/follicular-delivery-of-spironolactone-via-nanostructured-lipid-carrier-peer-reviewed-article-IJN
work_keys_str_mv AT shammarn folliculardeliveryofspironolactoneviananostructuredlipidcarriersformanagementofnbspalopecia
AT aburahmamh folliculardeliveryofspironolactoneviananostructuredlipidcarriersformanagementofnbspalopecia
_version_ 1725829407272075264